ABOUT US

leaders in digestive diseases

Centre of excellence

The Centre for Digestive Diseases’ (CDD) mission is to provide our patients with the best possible care. We take great pride in our facilities and personnel who continuously strive to achieve excellence in every aspect of our organisation.

CUTTING-EDGE TECHNOLOGIES & THERAPIES

The Hospital features cutting-edge technologies enabling our specialists to provide world-class treatments. For instance, the CDD is one of the few institutions offering infrared coagulation (IRC) which promotes fast healing of haemorrhoids with relatively minimal discomfort. This and other treatments we offer allow for a more comfortable experience for our patients.

PRIVACY & COMPASSION

Physicians and nurses at the CDD understand the personal difficulties associated with gastrointestinal (GI) related disorders. Under the leadership of Founder and Medical Director Professor Thomas Borody, there is a focus on delivery of unique treatments and therapies.

We endeavor to establish meaningful relationships with our patients, maintain strict standards of privacy and compassion, and ensure that the efficacy of treatments means the highest chance of success.

A dedicated talented team

Internationally recognised

Professional leadership

DIAGNOSIS, TREATMENT & RESEARCH

The CDD, under the leadership of founder and Medical Director, Professor Thomas Borody, has distinguished itself as a unique medical institution offering novel approaches in researching, diagnosing and treating gastrointestinal (GI) conditions.

ISO 9002 ACCREDITED 

The CDD offers a range of services in the day-procedure unit which is a well-equipped facility supported by an ISO 9002 accredited team of 50 staff. The CDD offers patients an exceptional standard of professional care and service.

The CDD also houses a Department of Research and Innovation responsible for conducting clinical trials approved by an independent Human Research Ethics Committee (HREC).

INTERNATIONALLY RECOGNISED

Located in Sydney Australia, CDD is internationally regarded as a leading medical institution, collaborating with pharmaceutical companies, universities and medical societies to provide excellence in gastroenterology.

Milestones

CDD Founder Professor Thomas Borody

1972

Professor Thomas Borody pioneers Faecal Microbiota Transplantation (FMT) in Australia

1980

Professor Thomas Borody Senior Medical Registrar: St Vincent’s Hospital

1981

Professor Thomas Borody Mayo Clinic, Rochester, MN, USA Fellowship

1984

Professor Thomas Borody established the Centre for Digestive Diseases in Sydney, Australia

1987

Professor Thomas Borody developed the triple therapy treatment for Peptic Ulcer

2000

The CDD under the director of Professor Borody develops treatments for digestive diseases including Crohn’s disease

2007 - current

Professor Thomas Borody: Consulting Gastroenterologist Strathfield Private Hospital, Strathfield

2014

Professor Thomas Borody: Faecal microbiota transplantation (FMT) for chronic active ulcerative colitis (FOCUS) study

2015

Launch of global clinical trials of the Crohn’s therapy developed at CDD

CDD data

Some of our numbers

220Scientific papers published
78000Patients treated
143Therapy or device patents
14CDD inventions in market or trials